Clinical Conditions of Hepatitis B
Clinical Conditions of Hepatitis B
Hepatitis B usually presents as an acute infection and rarely becomes chronic or lasts for more
than six months. It has an average 45-90 day incubation period which is followed by its clinical
course varying for different patient age groups. More than 90% of perinatal HBV newborns
remain asymptomatic while the typical symptoms associated with acute hepatitis manifest in
about 5-15% of children between the ages of 1-5 years old and in 33-50% of older children,
adolescents and adults. Hepatitis B patients usually recover from the infection even if they
sustained severe signs and symptoms. The symptoms of HBV can last for a period of weeks or
months where patients will recover within 6 months and build immunity to the virus. However,
infants and children typically develop chronic hepatitis B infection. Chronic hepatitis B increases
an individual's risk of developing liver failure, cancer or cirrhosis. Only 1% of HBV patients
will develop fulminant liver disease which has a high mortality rate. [1]
Chronic hepatitis occurs as the infection remains in the body for 6 or more months, unrelated to
age: chronic hepatitis B develops in around 10 percent of infected adults, 25-50 percent of small
children and 80-90 percent of infected babies. Chronic infection typically occurs in HIV and
immunosuppressed individuals. Chronic infection results in inflammation and damage to the
liver thus increasing the patient’s risk of developing cirrhosis; this was observed in 20% of
chronic HBV patients or highly increased risk of developing hepatocellular carcinoma. [1]
The hepatitis B vaccine was composed of HBsAg from inactivated viral particles from HBV
patients’ plasma in 1982 but was then changed to consist of recombinant HbsAg thats produced
from genetically engineered yeast. The vaccine is given to newborn babies and young children
as part of the usual immunization process. It is also recommended for chancy individuals like
health-care workers, homosexual men, hemodialysis patients, persons with multiple sexual
partners and infants born to HBV-infected mothers.WHO recommends 2-3 doses of the hepatitis
B vaccine for all babies. The first dose should be administered within 24 hours of birth and then
2 or 3 more doses to be followed. Chronic Hepatitis B affects almost 300 million people and kills
700,000 people internationally on an annual basis. Vaccination has been extremely prosperous in
the decline of HBV.
Furthermore to vaccination, HBV can also be prevented by simply
● washing hands properly with soap and water after exposure to blood.
● the use of condoms and
● less direct contact with blood and bodily fluids. [2]
References
1. Hepatitis B FAQs | CDC [Internet]. Centers for Disease Control and Prevention. 2020 [cited 3
January 2021]. Available from: https://www.cdc.gov/hepatitis/hbv/bfaq.htm
2. Preventing Hepatitis B [Internet]. Cdc.gov. 2020 [cited 3 January 2021]. Available from:
https://www.cdc.gov/globalhealth/immunization/othervpds/preventing_hepatitisb.html#:~:text=T
he%20best%20way%20to%20prevent,or%203%20additional%20doses%20later.